The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
The use of mass spectrometry to improve the diagnosis and the management of the HPA axis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Over the last years, newer-generation assays with greater specificity for cortisol have been developed and have replaced the old assays in almost all the centers.”
From ACTH Stimulation Test for the Diagnosis of Secondary Adrenal Insufficiency: Light and Shadow (2023) · cites this paper as [43]
In the citing paper
“The new tools available to detect cortisol are the immunoassays utilizing monoclonal antibodies, such as Elecsys Cortisol generation II and Beckman Access Cortisol, and the Liquid chromatography–tandem mass spectrometry (LC-MS/MS), which is a non-antibody structural assay highly specific for cortisol [41,42,43,44].”
From ACTH Stimulation Test for the Diagnosis of Secondary Adrenal Insufficiency: Light and Shadow (2023) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
Funder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0104 · Cited by 1,554
Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement
Biller, B. M. K., Grossman, A. B., Stewart, P. M., Melmed, S., Bertagna, X., Bertherat, J., Buchfelder, M., Colao, A., Hermus, A. R., Hofland, L. J., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2734 · Cited by 853
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors
Arlt, W., Biehl, M., Taylor, A. E., Hahner, S., Libé, R., Hughes, B. A., Schneider, P., Smith, D. J., Stiekema, H., Krone, N., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1565 · Cited by 458
Management of patients with adrenal cancer: recommendations of an international consensus conference
Schteingart, D. E., Doherty, G. M., Gauger, P. G., Giordano, T. J., Hammer, G. D., Korobkin, M., & Worden, F. P. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01029 · Cited by 421
Beishuizen, A., Thijs, L. G., & Vermes, I. (2001) · Intensive Care Medicine · doi:10.1007/s001340101073 · Cited by 245
Salivary cortisone is a potential biomarker for serum free cortisol
Perogamvros, I., Keevil, B. G., Ray, D. W., & Trainer, P. J. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1215 · Cited by 222
Self-citationLegro, R. S., Schlaff, W. D., Diamond, M. P., Coutifaris, C., Casson, P. R., Brzyski, R. G., Christman, G. M., Trussell, J. C., Krawetz, S. A., Snyder, P. J., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1123 · Cited by 213
Late-night salivary cortisol as a screening test for cushing's syndrome
Raff, H. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2681 · Cited by 194
Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency
Raff, H. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1166 · Cited by 186
Research works printed but not linked: 62
- Hoofnagle AN, Wener MH. The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. J Immunol Methods. 2009;347(1–2):3–11. · DOI · Paper page
- Sturgeon CM, Viljoen A. Analytical error and interference in immunoassay: Minimizing risk. Ann Clin Biochem. 2011;48:418–32. · DOI · Paper page
- Bell DA, Florkowski CM, Lewis JG, Crooke MJ. Plasma poltergeists: a negative cortisol interference leading to a false diagnosis of adrenal insufficiency. Clin Chim Acta. 2012;413(15–16):1298–300. · DOI
- Tate J, Ward G. Interferences in immunoassay. Clin Biochem Rev. 2004;25(2):105–20.
- Kushnir MM, Rockwood AL, Roberts WL, Yue B, Bergquist J, Meikle AW. Liquid chromatography tandem mass spectrometry for analysis of steroids in clinical laboratories. Clin Biochem. 2011;44:77–88. · DOI · Paper page
- Taylor PJ. Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin Biochem. 2005;38(4):328–34. · DOI · Paper page
- Vogeser M, Seger C. Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory. Clin Chem. 2010;56(8):1234–44. · DOI · Paper page
- Annesley TM. Methanol-associated matrix effects in electrospray ionization tandem mass spectrometry. Clin Chem. 2007;53(10):1827–34. · doi:10.1373/clinchem.2007.090811
- Van Eeckhaut A, Lanckmans K, Sarre S, Smolders I, Michotte Y. Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects. J Chromatogr B Anal Technol Biomed Life Sci. 2009;877:2198–207. · DOI · Paper page
- Annesley TM. Ion suppression in mass spectrometry. Clin Chem. 2003;49(7):1041–4. · DOI · Paper page
- Ionita IA, Fast DM, Akhlaghi F. Development of a sensitive and selective method for the quantitative analysis of cortisol, cortisone, prednisolone and prednisone in human plasma. J Chromatogr B Anal Technol Biomed Life Sci. 2009;877(8–9):765–72. · DOI
- Duxbury K, Owen LJ, Gillingwater S, Keevil BG. Naturally occurring isotopes of an analyte can interfere with doubly deuterated internal standard measurement. Ann Clin Biochem. 2008;45:210–2. · doi:10.1258/acb.2007.007137
- Honour JW. Development and validation of a quantitative assay based on tandem mass spectrometry. Ann Clin Biochem. 2011;48:97–111. · DOI
- Owen LJ, Keevil BG Testosterone measurement by mass spectrometry – a tale of three internal standards. Presented at Society for Endocrinology BES 2012, Harrogate, UK. Endocrine Abstracts, 2012;28:P30.
- Mendel CM. The free hormone hypothesis. Distinction from the free hormone transport hypothesis. J Androl. 1992;13(2):107–16. · DOI
- van Seters AP, Moolenaar AJ. Mitotane increases the blood levels of hormone-binding proteins. Acta Endocrinol. 1991;124(5):526–33. · DOI
- Alexandraki KI, Kaltsas GA, le Roux CW, Fassnacht M, Ajodha S, Christ-Crain M, et al. Assessment of serum-free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study. Clin Endocrinol. 2010;72:305–11. · DOI
- Veytsman I, Nieman L, Fojo T. Management of endocrine manifestations and the use of mitotane as a chemotherapeutic agent for adrenocortical carcinoma. J Clin Oncol. 2009;27(27):4619–29. · DOI
- Cameron A, Henley D, Carrell R, Zhou A, Clarke A, Lightman S. Temperature-responsive release of cortisol from its binding globulin: a protein thermocouple. J Clin Endocrinol Metab. 2010;95(10):4689–95. · DOI
- Vogeser M, Briegel J, Zachoval R. Dialyzable free cortisol after stimulation with synacthen. Clin Biochem. 2002;35(7):539–43. · DOI
- Perogamvros I, Kayahara M, Trainer PJ, Ray DW. Serum regulates cortisol bioactivity by corticosteroid-binding globulin dependent and independent mechanisms, as revealed by combined bioassay and physicochemical assay approaches. Clin Endocrinol. 2011;75(1):31–8. · DOI
- Kirchhoff F, Briegel J, Vogeser M. Quantification of free serum cortisol based on equilibrium dialysis and isotope dilution-liquid chromatography-tandem mass spectrometry. Clin Biochem. 2011;44(10–11):894–9. · DOI
- Lee S, Kwon S, Shin HJ, Lim HS, Singh RJ, Lee K-R, et al. Simultaneous quantitative analysis of salivary cortisol and cortisone in Korean adults using LC-MS/MS. BMB Reps. 2010;43(7):506–11. · DOI
- Raff H, Findling JW. Biomarkers: salivary cortisol or cortisone? Nat Rev Endocrinol. 2010;6(12):658–60. · DOI
- Jones RL, Owen LJ, Adaway JE, Keevil BG. Simultaneous analysis of cortisol and cortisone in saliva using XLC-MS/MS for fully automated online solid phase extraction. J Chromatogr B Anal Technol Biomed Life Sci. 2012;881–882, 42–48. · DOI · Paper page
- Restituto P, Galofré JC, Gil MJ, Mugueta C, Santos S, Monreal JI, et al. Advantage of salivary cortisol measurement ion the diagnosis of glucocorticoid related disorders. Clin Biochem. 2008;41:688–92. · DOI
- Deutschbein T, Unger N, Mann K, Petersenn S. Diagnosis of secondary adrenal insufficiency: unstimulated early morning cortisol saliva and serum in comparison with the insulin tolerance test. Horm Metab Res. 2009;41:834–9. · DOI
- Deutschbein T, Broecker-Preuss M, Flitsch J, Jaeger A, Althoff R, Walz MK, et al. Salivary cortisol as a diagnostic tool for Cushing’s syndrome and adrenal insufficiency: improved screening by an automatic immunoassay. Eur J Endocrinol. 2012;166:613–8. · DOI · Paper page
- Fiad TM, Kirby JM, Cunningham SK, McKenna TJ. The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol. 1994;40(5):603–9. · DOI · Paper page
- Gibney J, Healy M-L, Smith TP, McKenna TJ. A simple and cost-effective approach to assessment of pituitary adrenocorticotropin and growth hormone reserve: combined use of the overnight metyrapone test and insulin-like growth factor-I standard deviation scores. J Clin Endocrinol Metab. 2008;93(10):3763–8. · DOI
- Koal T, Schmiederer D, Pham-Tuan H, Röhring C, Rauh M. Standardized LC-MS/MS based steroid hormone profile-analysis. J Steroid Biochem Mol Biol. 2012;129:129–38. · DOI · Paper page
- Casale TB, Nelson HS, Stricker WE, Raff H, Newman KB. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients. Ann Allergy Asthma Immunol. 2001;87(5):379–85. · DOI
- Taylor RL, Grebe SK, Singh RJ. Quantitative, highly sensitive liquid chromatography-tandem mass spectrometry method for detection of synthetic corticosteroids. Clin Chem. 2004;50(12):2345–52. · DOI
- Taylor NF, Chan AOK. New strategies for detecting steroid metabolic disorders-panelling vs. profiling. Clin Chem. 2012;58(8):1262–3. · DOI
- Dhillon K, Ho T, Rich P, Xu D, Lorey F, She J, et al. An automated method on analysis of blood steroids using liquid chromatography tandem mass spectrometry: application to population screening for congenital adrenal hyperplasia in newborns. Clin Chim Acta. 2011;412:2076–84. · DOI
- Campbell DJ, Nussberger J, Stowasser M, Jan Danser AH, Morganti A, Frandsen E, et al. Activity assays and immunoassays for plasma renin and prorenin: information provided and precautions necessary for accurate measurement. Clin Chem. 2009;55(5):867–77. · DOI · Paper page
- Pizzolo F, Raffaelli R, Memmo A, Chiecchi L, Pavan C, Guarini P, et al. Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism. J Hypertens. 2010;28(1):135–42. · DOI
- Bystrom CE, Salameh W, Reitz R, Clarke NJ. Plasma renin activity by LC-MS/MS: development of a prototypical clinical assay reveals a subpopulation of human plasma samples with substantial peptidase activity. Clin Chem. 2010;56(10):1561–9. · DOI
- Sealey JE, Laragh JH. Plasma renin activity enzyme-kinetic assay: protection of angiotensin I from bacterial degradation. Clin Chem. 2011;57(3):529–30. · DOI
- Carter S, Owen LJ, Kerstens MN, Dullaart RPF, Keevil BG. A liquid chromatography tandem mass spectrometry assay for plasma renin activity using online solid-phase extraction. Ann Clin Biochem. 2012;49:570–9. · DOI
- Schirpenbach C, Seiler L, Maser-Gluth C, Beuschlein F, Reincke M, Bidlingmaier M. Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps. Clin Chem. 2006;52(9):1749–55. · DOI
- Turpeinen U, Hamalainen E, Stenman UH. Determination of aldosterone in serum by liquid chromatography-tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci. 2008;862(1–2):113–8. · DOI
- Taylor PJ, Cooper DP, Gordon RD, Stowasser M. Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry. Clin Chem. 2009;55(6):1155–62. · DOI
- Van Der Gugten JC, Dubland J, Liu HF, Wang A, Joseph C, Holmes DT. Determination of serum aldosterone by liquid chromatography and tandem mass spectrometry: a liquid-liquid extraction method for the ABSCIEX API-5000 mass spectrometry system. J Clin Pathol. 2012;65(5):457–62. · DOI
- Guo T, Taylor RL, Singh RJ, Soldin SJ. Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem mass spectrometry. Clin Chim Acta. 2006;372(1–2):76–82. · DOI · Paper page
- Djedovic NK, Rainbow SJ. Detection of synthetic glucocorticoids by liquid chromatography-tandem mass spectrometry in patients being investigated for Cushing’s syndrome. Ann Clin Biochem. 2011;48:542–9. · DOI
- Remer T, Maser-Gluth C. Simultaneous measurement of urinary free cortisol and cortisone for the assessment of functional glucocorticoid activity. Clin Chem. 2007;53(10):1870–1. · DOI
- Hempen C, Elfering S, Mulder AHL, van den Bergh FAJTM, Maatman RGHJ. Dexamethasone suppression test: development of a method for simultaneous determination of cortisol and dexamethasone in human plasma by liquid chromatography/tandem mass spectrometry. Ann Clin Biochem. 2012;49:170–6. · DOI
- Peng C-C, Templeton I, Thummel KE, Davis C, Kunze KL, Isoherranen N. Evaluation of 6β-hydroxycortisol, 6β-hydroxycortisone, and a combination of the two as endogenous probes for inhibition of CYP3A4 in vivo. Clin Pharmacol Ther. 2011;89(6):888–95. · DOI
- Zerikly RK, Amiri L, Faiman C, Gupta M, Singh RJ, Nutter B, et al. Diagnostic characteristics of late-night salivary cortisol using liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab. 2010;95(10):4555–9. · DOI
- Erickson D, Singh RJ, Sathananthan A, Vella A, Bryant SC. Late-night salivary cortisol for diagnosis of Cushing’s syndrome by liquid chromatography/tandem mass spectrometry. Clin Endocrinol. 2012;76:467–72. · DOI
- Gröschl M. Current status of salivary hormone analysis. Clin Chem. 2008;54(11):1759–69. · DOI · Paper page
- Raff H. Salivary cortisol and the diagnosis of Cushing’s syndrome: a coming of age. Endocrine. 2012;41(3):353–4. · DOI
- Ceglarek U, Werner M, Kortz L, Körner A, Kiess W, Thiery J, et al. Preclinical challenges in steroid analysis of human samples. J Steroid Biochem Mol Biol. 2010;121:505–12. · DOI
- Tritos NA, Biller BMK. Advances in medical therapies for Cushing’s syndrome. Discov Med. 2012;13(69):171–9.
- Turner HE, Wass JAH. Oxford handbook of endocrinology and diabetes; a comprehensive guide to clinical management. 2nd ed. Oxford: Oxford University Press; 2009. p. 148. · DOI
- Trainer PJ, Eastment C, Grossman AB, Wheeler MJ, Perry L, Besser GM. The relationship between cortisol production rate and serial serum cortisol estimation in patients on medical therapy for Cushing’s syndrome. Clin Endocrinol. 1993;39:441–3. · DOI
- McWhinney BC, Ward G, Pickman PE. Improved HPLC method for simultaneous analysis of cortisol, 11-deoxycortisol, prednisolone, methylprednisolone, and dexamethasone in serum and urine. Clin Chem. 1996;42:979–81. · DOI
- Monaghan PJ, Owen LJ, Trainer PJ, Brabant G, Keevil BG, Darby D. Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11β-hydroxylase inhibitor metyrapone. Ann Clin Biochem. 2011;48:441–6. · DOI · Paper page
- Monaghan PJ, Owen LJ, Trainer PJ, Brabant G, Keevil BG, Darby D. Response to ‘Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11β-hydroxylase inhibitor metyrapone’ by Halsall, et al. Ann Clin Biochem. 2012;49(2):204–5. · DOI
- Schmidt-Reinwald A, Pruessner JC, Hellhammer DH, Federenko I, Rohleder N, Schürmeyer TH, et al. The cortisol response to awakening in relation to different challenge tests and a 12-hour cortisol rhythm. Life Sci. 1999;64(18):1653–60. · DOI · Paper page
- van den Ouweland JMW, Kema IP. The role of liquid chromatography-tandem mass spectrometry in the clinical laboratory. J Chromatogr B Anal Technol Biomed Life Sci. 2012;883–884:18–32. · DOI · Paper page
Cited by
Daniel, E., Aylwin, S., Mustafa, O., Ball, S., Munir, A., Boelaert, K., Chortis, V., Cuthbertson, D. J., Daousi, C., Rajeev, S. P., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2616 · Cited by 231
“Thus, cortisol estimation by more accurate methods such as mass spectrometry is advisable, and should be used where available (27).”
MethodSelf-citationJavorsky, B. R., Raff, H., Carroll, T. B., Algeciras-Schimnich, A., Singh, R. J., Colón-Franco, J. M., & Findling, J. W. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab022 · Cited by 171
LC–MS/MS analysis of steroids in the clinical laboratory
Keevil, B. G. (2016) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2016.04.009 · Cited by 149
Self-citationAntonelli, G., Ceccato, F., Artusi, C., Marinova, M., & Plebani, M. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.10.004 · Cited by 111
Plasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma
Schweitzer, S., Kunz, M., Kurlbaum, M., Vey, J., Kendl, S., Deutschbein, T., Hahner, S., Fassnacht, M., Dandekar, T., & Kroiss, M. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0782 · Cited by 85
Metadata
- Authors
- Monaghan, P. J., Keevil, B. G., & Trainer, P. J.
- Venue
- Reviews in Endocrine and Metabolic Disorders
- Published
- 2013-03-15
- Volume
- 14
- Issue
- 2
- Pages
- 143-157
- ISSN
- 1389-9155
- 1573-2606
- Cited by
- 28
- References
- 23
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The use of mass spectrometry to improve the diagnosis and the management of the HPA axis. https://app.cochat.ai/papers/10.1007/s11154-013-9240-1
- The paper
- Monaghan, P. J., Keevil, B. G., & Trainer, P. J. (2013). The use of mass spectrometry to improve the diagnosis and the management of the HPA axis. Reviews in Endocrine and Metabolic Disorders. https://doi.org/10.1007/s11154-013-9240-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.